Global Cervical Cancer Diagnostics Market 2022 Report:

Dublin, Oct 03, 2022 (GLOBE NEWSWIRE) – The report “Cervical Cancer Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunities, and 2022-2027 Forecast” has been added to by offer.

The size of the global cervical cancer diagnostics market reached $ 7.1 billion in 2021. Looking ahead, the publisher expects the market to reach $ 9.9 billion by 2027, exhibiting a CAGR of 5. , 7% in the period 2021-2027. With the uncertainties of COVID-19 in mind, we continuously monitor and evaluate the direct and indirect influence of the pandemic. This information is included in the report as a major contributor to the market.

Cervical cancer diagnostics is based on a series of advanced laboratory tests, tools and procedures to evaluate abnormal human papillomavirus (HPV) cells or strains. They are performed by taking a sample of the tissue obtained by conization, punch biopsy, endocervical curettage and the wire loop for a thorough examination of the cervix during colposcopy. After detection, tests such as blood, chest X-ray, computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), and visual examination of the bladder and rectum are conducted to determine the stage of the disease.

A considerable increase in the number of individuals diagnosed with sexually transmitted infections (STIs), such as syphilis, chlamydia, gonorrhea, and acquired immunodeficiency syndrome (HIV / AIDS), is increasing the risk of HPV infection worldwide. This, coupled with the growing number of smokers, which increases the chances of developing cervical cancer, is one of the key factors in supporting market growth.

Additionally, the growing awareness of early detection is encouraging the adoption of home HPV test kits that provide fast and accurate test results. The presence of favorable reimbursement policies also supports market growth. In addition to this, the growing preferences for personalized treatment plans are increasing the demand for cervical cancer diagnostics.

In addition, the availability of a number of other treatment options, including surgery, radiation therapy, chemotherapy, cone biopsy, immunotherapy and trachelectomy, is contributing to the growth of the market. Furthermore, the growing emphasis on developing efficient and low-cost test products is expected to fuel market growth.

Key market segmentation

Breakdown by test type:

  • PAP test
  • HPV test
  • Cervical biopsies
  • colposcopy
  • Other

Breakdown by age group:

  • From 20 to 35 years
  • Above 35 years old

Breakdown by region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Other
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Other
  • Latin America
  • Brazil
  • Mexico
  • Other
  • Middle East and Africa

Key questions answered in this report:

  • How has the global cervical cancer diagnostics market performed so far and how will it behave in the coming years?
  • What has been the impact of COVID-19 on the global cervical cancer diagnostics market?
  • What are the main regional markets?
  • What is the market break based on the type of test?
  • What is the break in the market based on the age group?
  • What are the various stages of the industry value chain?
  • What are the key drivers and challenges in the industry?
  • What is the structure of the global Cervical Cancer Diagnostics market and who are the key players?
  • What is the degree of competition in the industry?

Key topics covered:

1 Preface

2 Scope and methodology

3 Executive summary

4 Introduction

5 Global Cervical Cancer Diagnostics Market

6 Breakdown of the market by type of test

7 Breakdown of the market by age group

8 Market breakdown by region

9 SWOT Analysis

10 Value chain analysis

11 Porter’s Five Forces Analysis

12 Price analysis

13 Competitive landscape

Companies mentioned

  • Abbott Laboratories
  • Arbor Vita Corporation
  • Becton Dickinson and company
  • Cooper Surgical Inc.
  • F. Hoffmann-La Roche AG
  • Guided Therapeutics Inc.
  • Hologic Inc.
  • qiagen
  • Quest Diagnostics Incorporated
  • Siemens Healthcare GmbH.

For more information on this report, please visit

  • Global market for cervical cancer diagnostics



Leave a Comment

%d bloggers like this: